Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M40,215Revenue $M10,235Net Margin (%)16.6Z-Score3.4
Enterprise Value $M44,037EPS $3.6Operating Margin %20.8F-Score6
P/E(ttm))26.8Cash Flow Per Share $5.3Pre-tax Margin (%)19.8Higher ROA y-yN
Price/Book4.010-y EBITDA Growth Rate %7.4Quick Ratio1.3Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %6.7Current Ratio1.8Lower Leverage y-yY
Price/Cash Flow11.0y-y EBITDA Growth Rate %-11.3ROA % (ttm)8.5Higher Current Ratio y-yN
Dividend Yield %1.4Insider Buy (3m)2ROE % (ttm)18.4Less Shares Outstanding y-yY
Payout Ratio %37.0Shares Outstanding M451ROI % (ttm)10.6Gross Margin Increase y-yY

Gurus Latest Trades with COV

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
COVJohn Paulson 2014-06-30 Buy 2.7%$69.03 - $91.24
($74.56)
$ 89.0219%New holding, 7000000 sh.7,000,000
COVGeorge Soros 2014-06-30 Buy 0.15%$69.03 - $91.24
($74.56)
$ 89.0219%New holding, 227000 sh.227,000
COVJoel Greenblatt 2014-06-30 Sold Out $69.03 - $91.24
($74.56)
$ 89.0219%Sold Out0
COVYacktman Focused Fund 2014-06-30 Sold Out -0.62%$69.03 - $91.24
($74.56)
$ 89.0219%Sold Out0
COVYacktman Fund 2014-06-30 Sold Out -0.56%$69.03 - $91.24
($74.56)
$ 89.0219%Sold Out0
COVDonald Yacktman 2014-06-30 Sold Out -0.55%$69.03 - $91.24
($74.56)
$ 89.0219%Sold Out0
COVRay Dalio 2014-06-30 Sold Out -0.03%$69.03 - $91.24
($74.56)
$ 89.0219%Sold Out0
COVJoel Greenblatt 2014-03-31 Buy $66.35 - $72.5
($69.62)
$ 89.0228%New holding, 3746 sh.3,746
COVRay Dalio 2014-03-31 Reduce-0.02%$66.35 - $72.5
($69.62)
$ 89.0228%Reduce -41.8%47,058
COVVanguard Health Care Fund 2013-12-31 Add0.22%$59.82 - $68.42
($65.08)
$ 89.0237%Add 24.79%4,994,700
COVRay Dalio 2013-12-31 Buy 0.04%$59.82 - $68.42
($65.08)
$ 89.0237%New holding, 80858 sh.80,858
COVJohn Keeley 2013-12-31 Reduce-0.06%$59.82 - $68.42
($65.08)
$ 89.0237%Reduce -52.66%44,520
COVJoel Greenblatt 2013-12-31 Sold Out -0.03%$59.82 - $68.42
($65.08)
$ 89.0237%Sold Out0
COVJoel Greenblatt 2013-09-30 Reduce-0.08%$57.12 - $63.8
($61.08)
$ 89.0246%Reduce -64.08%16,584
COVVanguard Health Care Fund 2013-06-30 Add0.37%$50.69 - $56.84
($54.09)
$ 89.0265%Add 66.94%4,002,600
COVJoel Greenblatt 2013-06-30 Buy 0.12%$50.69 - $56.84
($54.09)
$ 89.0265%New holding, 46170 sh.46,170
COVRonald Muhlenkamp 2013-06-30 Reduce-2.78%$50.69 - $56.84
($54.09)
$ 89.0265%Reduce -53.5%174,170
COVJean-Marie Eveillard 2013-06-30 Reduce-0.16%$50.69 - $56.84
($54.09)
$ 89.0265%Reduce -99.79%1,500
COVLeon Cooperman 2013-06-30 Sold Out -0.04%$50.69 - $56.84
($54.09)
$ 89.0265%Sold Out0
COVRay Dalio 2013-06-30 Sold Out -0.04%$50.69 - $56.84
($54.09)
$ 89.0265%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

COV is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
COV George Soros 2014-06-30227,0000.050.15New Buy
COV John Paulson 2014-06-307,000,0001.552.7New Buy
COV Mario Gabelli 2014-06-30637,5300.140.3+17.29%
COV Ronald Muhlenkamp 2014-06-30182,1800.042.9+0.4%
COV Vanguard Health Care Fund 2014-06-304,994,7001.111.2
COV Jean-Marie Eveillard 2014-06-301,50000
COV John Keeley 2014-06-3040,8400.010.07-6.69%
COV Dodge & Cox 2014-06-3092,0170.020.01-9.36%
COV Donald Yacktman 2014-06-30000Sold Out
COV Ray Dalio 2014-06-30000Sold Out
COV Joel Greenblatt 2014-06-30000Sold Out
COV Yacktman Fund 2014-06-30000Sold Out
COV Yacktman Focused Fund 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


COV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lannum Coleman N IIIVice President 2014-08-19Buy1,720$87.821.36view
Lannum Coleman N IIIVice President 2014-08-18Buy4,100$87.581.63view
BROWN RICHARD G JRVice President and Controller 2014-08-18Buy2,000$87.691.51view
ALMEIDA JOSE EPresident and Chief Executive 2014-06-16Sell51,166$92.05-3.3view
King Brian DouglasVice President 2014-04-29Sell15,569$70.1126.96view
Dockendorff Charles JEVP & CFO 2014-03-28Sell90,730$72.522.77view
ALMEIDA JOSE EPresident and Chief Executive 2014-02-28Sell50,000$7223.63view
Lannum Coleman N IIIVice President 2014-02-18Sell3,200$71.424.66view
BROWN RICHARD G JRVice President and Controller 2014-02-13Sell4,000$7125.37view
Lannum Coleman N IIIVice President 2014-02-12Sell961$70.2226.76view

Press Releases about COV :

    Quarterly/Annual Reports about COV:

    News about COV:

    Articles On GuruFocus.com
    A Strong Candidate for Investor´s Portfolios Aug 12 2014 
    The Gabelli Equity Income Fund Second Quarter 2014 Shareholder Commentary Jul 25 2014 
    Steven Romick's Top Five Stocks Jul 11 2014 
    American Water Works - Nice Steady Upward Jun 21 2014 
    Major British Companies Lead Top Guru-Held UK and Ireland Stocks Jun 10 2014 
    4 Top Stocks in the Medical Device Sector Apr 11 2014 
    Weekly Insider Sells Highlight: CUK, CBI, COV, DWRE Mar 30 2014 
    Weekly CFO Sells Highlight: Chicago Bridge and Iron Company, Covidien PLC, Carnival PLC, Google Inc. Mar 30 2014 
    We Are Confident About Baxter's Plan to Create Two Separate Health Care Companies Mar 28 2014 
    Can Malllinckrodt Keep on Crushing Expectations? Mar 19 2014 


    More From Other Websites
    [$$] FDA Approves Changes to Production of Recalled Covidien Devices Aug 21 2014
    7:01 am Covidien announces FDA approved changes to manufacturing process for polytetrafluoroethylene... Aug 21 2014
    FDA Approves Changes to Manufacturing Process for Covidien’s Pipeline™ Embolization Device Aug 21 2014
    Covidien Opens Advanced Medical Technology Center in Brazil Aug 20 2014
    The Law Office of Robbins Arroyo LLP Announces That it Has Filed a Class Action Lawsuit Against... Aug 19 2014
    Medtronic CEO says Covidien deal good for U.S. economy Aug 19 2014
    Medtronic (MDT) Q1 Earnings, Revenues Beat; Margins Drop Aug 19 2014
    [$$] Medtronic Tops Views, Backs Covidien Bid Aug 19 2014
    Medtronic first-quarter profit tops expectations Aug 19 2014
    Study Published in JACC CI Demonstrates Directional Atherectomy Effective as Frontline Therapy for... Aug 18 2014
    M&A: When two companies love each other very much... Aug 14 2014
    Harvard Management Co invested in Covidien in Q2 - filing Aug 13 2014
    [$$] Medtronic's Tax Inversion Lesson Aug 13 2014
    INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Covidien plc of Class Action Against Its... Aug 12 2014
    Stampede of Mergers Could Mean Growth, or Irrationality, Ahead Aug 07 2014
    [video] Future of inversions Aug 07 2014
    [$$] U.S. Seeks More Information on Medtronic's Covidien Deal Aug 07 2014
    Obama: Congress should end 'tax inversions' Aug 06 2014
    [video] Inversions in health care Aug 06 2014
    COVIDIEN PLC Financials Aug 06 2014
    Obama Is Considering Bypassing Congress To Try To Stop Companies From Leaving America To Save On... Aug 05 2014
    Wall Street Transcript Interview with Terrance H. Gregg, the CEO of Dexcom, Inc. (DXCM) Aug 01 2014
    Analysis - Ireland has too much to lose to deter U.S. companies re-homing Jul 30 2014
    Covidien Expands Internship Program, And With It, Engineering Hiring Pipeline Jul 24 2014
    Covidien Launches EverFlex™ Self-expanding Peripheral Stent with Entrust™ Delivery System in... Jul 10 2014
    Covidien Ranks First in IR Magazine US Top 100 Jul 09 2014
    AbbVie urges Shire to enter takeover talks Jun 25 2014
    Medtronic, Covidien match up on services strategy before deal Jun 16 2014
    Medtronic's Covidien deal raises bar for rivals to merge Jun 16 2014
    US STOCKS-Wall St ends up slightly on M&A; Iraq closely watched Jun 16 2014
    US STOCKS-Wall St inches up on M&A deals; Iraq worries cap gains Jun 16 2014
    Medtronic to buy Covidien for $42.9 billion, rebase in Ireland Jun 16 2014
    Announcement under Irish Takeover Rules Relevant Securities in Issue Jun 16 2014
    Britain's FTSE slips as prospect of Smith & Nephew takeover fades Jun 16 2014
    Medical device maker Medtronic to buy Covidien for $42.9 bn Jun 16 2014
    Medtronic to buy Covidien for $42.9 bln, rebase in Ireland Jun 15 2014
    Medtronic to buy Covidien for $42.9 billion, rebase in Ireland Jun 15 2014
    Medtronic to buy Covidien for $42.9 billion, rebase in Ireland Jun 15 2014
    Medical device maker Medtronic to buy Covidien for $42.9 bln Jun 15 2014
    Smith & Nephew misses out as Medtronic's head turned Jun 15 2014
    Smith & Nephew misses out as suitor Medtronic buys rival Jun 15 2014
    Medical device maker Medtronic to buy Covidien for $42.9 bln Jun 15 2014
    Medtronic nears $45 billion-plus deal for Covidien - sources Jun 14 2014
    Medtronic nears $45 billion-plus deal for Covidien -sources Jun 14 2014
    Medical-device maker Medtronic in talks to buy Irish rival Jun 14 2014
    Medtronic in talks to combine with Covidien in $45 bln deal - source Jun 14 2014
    Medtronic in talks to combine with Covidien in $45 bln deal - source Jun 14 2014
    Covidien Announces CE Mark of Nellcor™ Respiration Rate Technology Jun 03 2014
    AORN Foundation, Covidien Team to Offer New Tools for Emerging Nurse Leaders Mar 28 2014
    Study Published in JAMA Shows Covidien Endoscopic Ablation Therapy Effective In Treating Barrett’s... Mar 25 2014
    Covidien Announces Results from 2014 Annual General Meeting Mar 19 2014
    Covidien Declares Quarterly Cash Dividend Mar 19 2014
    Covidien plc to Report Second-Quarter Fiscal 2014 Results on April 25, 2014 Mar 14 2014
    Covidien Launches Symbotex™ Composite Mesh for Surgical Laparoscopic and Open Ventral Hernia... Mar 13 2014
    Covidien to Present at Barclays Global Healthcare Conference 2014 Mar 06 2014
    Covidien Announces CE Mark Approval for Puritan Bennett™ 980 Ventilator Mar 03 2014
    Covidien Completes Acquisition of Given Imaging Feb 27 2014
    Covidien Announces U.S. Food and Drug Administration 510(k) Clearance for the Puritan Bennett™ 980... Feb 26 2014
    Covidien to Present at Raymond James 35th Annual Institutional Investors Conference Feb 24 2014
    Covidien Receives U.S. FDA 510(k) Clearance for Reinforced Stapling Reload Technology Feb 06 2014
    Covidien to Present at 2014 Leerink Global Healthcare Conference Feb 04 2014
    Covidien Receives Japanese Regulatory Approval for Reinforced Stapling Reload Technology Jan 27 2014
    Covidien CFO will retire at the end of 2014 Jan 27 2014
    Covidien Reports First-Quarter Fiscal 2014 Results Jan 24 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide